New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

The results showed that semaglutide led to noticeable changes in alcohol-related behavior ... with no heavy drinking days at all, especially during the second month of the study.

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy and used to treat coexisting conditions.

The small, 48-subject study – published ... The researchers found that semaglutide treatment did not affect average drinks per calendar day or number of drinking days over that period, but ...